- Home
- /
- Treatment
- /
- Page 9
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Artemisone | Malaria | Artemis Therapeutics, Inc.;18 East 16th Street, Suite 307;New York, New York, 10003 | July 19, 2017 | |
Ustekinumab | Pediatric systemic lupus erythematosus | Janssen Biotech, Inc.;800 Ridgeview Drive;Horsham, Pennsylvania, 19044 | July 18, 2017 | |
Filgotinib maleate | pediatric Crohn’s disease | Gilead Sciences, Inc.;199 E. Blaine St.;Seattle, Washington, 98102 | July 18, 2017 | |
One, two, three, or four antisense oligonucleotides of Phosphorodiamidate morpholino oligomer combination that skips exons 4, 5, 6, and 7 of the gamma sarcoglycan (SGCG) gene | Limb-girdle muscular dystrophy | Kurt+Peter Foundation;P. O. Box 691;Menlo Park, California, 94025 | July 18, 2017 | |
Recombinant human antibody directed against misfolded human superoxide dismutase 1 | Amyotrophic lateral sclerosis | The Medical & Regulatory Partnership Limited | July 17, 2017 | |
Polyphenyl(disodium 3-O-sulfo-beta-D-glucopyranuronate)-(1?3)-beta-D-galactopyranoside | Anti-MAG neuropathy | SFL Regulatory Affairs Consulting Ltd | July 17, 2017 | |
Retinol | Retinopathy of prematurity | orphanix GmbH | July 17, 2017 | |
Sirolimus | Pachyonychia Congenita | Raremoon Consulting Ltd | July 17, 2017 | |
Tirapazamine | Hepatocellular Carcinoma | PhaRA bvba | July 17, 2017 | |
(S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-yl)pyrimidin-5-yl)ethan-1-amine | Gastrointestinal stromal tumours | PhaRA bvba | July 17, 2017 | |
Oxymetazoline hydrochloride | Spinal cord injury | RDD Pharma Limited | July 17, 2017 | |
Autologous CD4+ and CD8+ T cells expressing a CD19-specific chimeric antigen receptor | Diffuse Large B-cell Lymphoma | Celgene Europe Limited | July 17, 2017 | |
Bacillus subtilisoxalate decarboxylase | Primary hyperoxaluria | Allena Pharmaceuticals Ireland Limited | July 17, 2017 | |
Ranpirnase | Ebola | Tamir Biotechnology, Inc.;51 John F Kennedy Parkway, 1st Floor West;Short Hills, New Jersey, 07078 | July 14, 2017 | |
(20S)-7-tert-butyldimethysilyl-10-hydroxycamptothecin | Glioblastoma | Vivacitas Oncology, Inc.;1990 North California Boulevard, 8th Floor;Walnut Creek, California, 94596 | July 13, 2017 | |
Autologous mononuclear cells derived from umbilical cord blood | Severe pediatric congenital heart disease | Timothy Nelson, MD, PhD;Mayo Clinic, Hypoplastic Left Heart Syndrome Program;Rochester, Minnesota, 55902 | July 13, 2017 | |
Electrokinetically altered saline solution with an elevated dissolved oxygen concentration | Amyotrophic lateral sclerosis | Revalesio Corporation;1202 East D Street;Tacoma, Washington, 98421 | July 10, 2017 | |
Cosyntropin | Duchenne muscular dystrophy | Mallinckrodt ARD Inc.;675 McDonnell Boulevard;Hazelwood, Missouri, 63042 | July 6, 2017 | |
Blinatumomab | Diffuse Large B-cell Lymphoma | Amgen Inc.;1 Amgen Center Drive;Thousand Oaks, California, 91320 | July 6, 2017 | |
Humanized immunoglobulin G4-variant monoclonal antibody directed against the p19 subunit of interleukin (IL)-23 | pediatric Crohn’s disease | Eli Lilly & Company;Lilly Corporate Center;Indianapolis, Indiana, 46285 | July 6, 2017 | |
Entrectinib | NTRK fusion-positive solid tumors | Ignyta, Inc.;4545 Towne Centre Court;San Diego, California, 92121 | July 5, 2017 | |
Sirukumab | Juvenile idiopathic arthritis (JIA) in pediatric patients | Janssen Research & Development, LLC;1400 McKean Road, P.O. Box 776;Spring House, Pennsylvania, 19477 | July 3, 2017 | |
Tadekinig alfa | Still’s disease | AB2 Bio Ltd;EPFL Innovation Park, Building B;Lausanne | July 3, 2017 | |
Small Molecule Bruton’s Agammaglobulinemia Tyrosine Kinase (BKT) Inhibitor | Pemphigus vulgaris | Principia Biopharma Inc.;400 East Jamie Court;South San Francisco, California, 94080 | June 29, 2017 | |
Oral tyrosine kinase inhibitor | Chronic myeloid leukemia | Fusion Pharma, LLC;Territory of the Skolkovo innovation center, Nobelya St. 7; | June 28, 2017 |